 | • レポートコード：B-GIR09D4322 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、テトラベナジンの世界市場について調べ、まとめました。種類別セグメントは、12.5 mg錠剤、25 mg錠剤等、用途別セグメントは、ハンチントン病、トゥレット症候群及びその他チック障害、遅発性ジスキネジア等に区分しました。テトラベナジンの世界市場概観、企業動向、企業別テトラベナジンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・テトラベナジンの市場概観 ・テトラベナジンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・テトラベナジンの企業別販売動向、市場シェア、市場集中度、競争動向 ・テトラベナジンの世界市場規模 ・テトラベナジンの北米市場分析（アメリカ、カナダ、メキシコ等） ・テトラベナジンのアメリカ市場規模推移 ・テトラベナジンのカナダ市場規模推移 ・テトラベナジンのメキシコ市場規模推移 ・テトラベナジンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・テトラベナジンのドイツ市場規模推移 ・テトラベナジンのイギリス市場規模推移 ・テトラベナジンのロシア市場規模推移 ・テトラベナジンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・テトラベナジンの日本市場規模推移 ・テトラベナジンの中国市場規模推移 ・テトラベナジンの韓国市場規模推移 ・テトラベナジンのインド市場規模推移 ・テトラベナジンの東南アジア市場規模推移 ・テトラベナジンの南米市場分析（ブラジル、アルゼンチン等） ・テトラベナジンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・テトラベナジンの種類別分析/販売量、売上、市場シェア（12.5 mg錠剤、25 mg錠剤） ・テトラベナジンの用途別分析/市場規模（ハンチントン病、トゥレット症候群及びその他チック障害、遅発性ジスキネジア） ・テトラベナジンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・テトラベナジンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders.
Scope of the Report:
The global Tetrabenazine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tetrabenazine.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Tetrabenazine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tetrabenazine market by product type and applications/end industries.
Market Segment by Companies, this report covers
Lundbeck
Hetero Labs Limited
Sun Pharmaceutical
Bionpharma
Lupin
Dr. Reddy’s Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
12.5 mg Tablets
25 mg Tablets
Market Segment by Applications, can be divided into
Huntington’s disease
Tourette syndrome and other tic disorders
Tardive dyskinesia
Table of Contents
1 Tetrabenazine Market Overview
1.1 Product Overview and Scope of Tetrabenazine
1.2 Classification of Tetrabenazine by Types
1.2.1 Global Tetrabenazine Revenue Comparison by Types (2019-2024)
1.2.2 Global Tetrabenazine Revenue Market Share by Types in 2018
1.2.3 12.5 mg Tablets
1.2.4 25 mg Tablets
1.3 Global Tetrabenazine Market by Application
1.3.1 Global Tetrabenazine Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Huntington’s disease
1.3.3 Tourette syndrome and other tic disorders
1.3.4 Tardive dyskinesia
1.4 Global Tetrabenazine Market by Regions
1.4.1 Global Tetrabenazine Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Tetrabenazine Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tetrabenazine Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tetrabenazine Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Tetrabenazine Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tetrabenazine Status and Prospect (2014-2024)
1.5 Global Market Size of Tetrabenazine (2014-2024)
2 Manufacturers Profiles
2.1 Lundbeck
2.1.1 Business Overview
2.1.2 Tetrabenazine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lundbeck Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
2.2 Hetero Labs Limited
2.2.1 Business Overview
2.2.2 Tetrabenazine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hetero Labs Limited Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sun Pharmaceutical
2.3.1 Business Overview
2.3.2 Tetrabenazine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sun Pharmaceutical Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bionpharma
2.4.1 Business Overview
2.4.2 Tetrabenazine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bionpharma Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
2.5 Lupin
2.5.1 Business Overview
2.5.2 Tetrabenazine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lupin Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dr. Reddy’s Laboratories
2.6.1 Business Overview
2.6.2 Tetrabenazine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr. Reddy’s Laboratories Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
3 Global Tetrabenazine Market Competition, by Players
3.1 Global Tetrabenazine Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Tetrabenazine Players Market Share
3.2.2 Top 10 Tetrabenazine Players Market Share
3.3 Market Competition Trend
4 Global Tetrabenazine Market Size by Regions
4.1 Global Tetrabenazine Revenue and Market Share by Regions
4.2 North America Tetrabenazine Revenue and Growth Rate (2014-2019)
4.3 Europe Tetrabenazine Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Tetrabenazine Revenue and Growth Rate (2014-2019)
4.5 South America Tetrabenazine Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Tetrabenazine Revenue and Growth Rate (2014-2019)
5 North America Tetrabenazine Revenue by Countries
5.1 North America Tetrabenazine Revenue by Countries (2014-2019)
5.2 USA Tetrabenazine Revenue and Growth Rate (2014-2019)
5.3 Canada Tetrabenazine Revenue and Growth Rate (2014-2019)
5.4 Mexico Tetrabenazine Revenue and Growth Rate (2014-2019)
6 Europe Tetrabenazine Revenue by Countries
6.1 Europe Tetrabenazine Revenue by Countries (2014-2019)
6.2 Germany Tetrabenazine Revenue and Growth Rate (2014-2019)
6.3 UK Tetrabenazine Revenue and Growth Rate (2014-2019)
6.4 France Tetrabenazine Revenue and Growth Rate (2014-2019)
6.5 Russia Tetrabenazine Revenue and Growth Rate (2014-2019)
6.6 Italy Tetrabenazine Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Tetrabenazine Revenue by Countries
7.1 Asia-Pacific Tetrabenazine Revenue by Countries (2014-2019)
7.2 China Tetrabenazine Revenue and Growth Rate (2014-2019)
7.3 Japan Tetrabenazine Revenue and Growth Rate (2014-2019)
7.4 Korea Tetrabenazine Revenue and Growth Rate (2014-2019)
7.5 India Tetrabenazine Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Tetrabenazine Revenue and Growth Rate (2014-2019)
8 South America Tetrabenazine Revenue by Countries
8.1 South America Tetrabenazine Revenue by Countries (2014-2019)
8.2 Brazil Tetrabenazine Revenue and Growth Rate (2014-2019)
8.3 Argentina Tetrabenazine Revenue and Growth Rate (2014-2019)
8.4 Colombia Tetrabenazine Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Tetrabenazine by Countries
9.1 Middle East and Africa Tetrabenazine Revenue by Countries (2014-2019)
9.2 Saudi Arabia Tetrabenazine Revenue and Growth Rate (2014-2019)
9.3 UAE Tetrabenazine Revenue and Growth Rate (2014-2019)
9.4 Egypt Tetrabenazine Revenue and Growth Rate (2014-2019)
9.5 Nigeria Tetrabenazine Revenue and Growth Rate (2014-2019)
9.6 South Africa Tetrabenazine Revenue and Growth Rate (2014-2019)
10 Global Tetrabenazine Market Segment by Type
10.1 Global Tetrabenazine Revenue and Market Share by Type (2014-2019)
10.2 Global Tetrabenazine Market Forecast by Type (2019-2024)
10.3 12.5 mg Tablets Revenue Growth Rate (2014-2024)
10.4 25 mg Tablets Revenue Growth Rate (2014-2024)
11 Global Tetrabenazine Market Segment by Application
11.1 Global Tetrabenazine Revenue Market Share by Application (2014-2019)
11.2 Tetrabenazine Market Forecast by Application (2019-2024)
11.3 Huntington’s disease Revenue Growth (2014-2019)
11.4 Tourette syndrome and other tic disorders Revenue Growth (2014-2019)
11.5 Tardive dyskinesia Revenue Growth (2014-2019)
12 Global Tetrabenazine Market Size Forecast (2019-2024)
12.1 Global Tetrabenazine Market Size Forecast (2019-2024)
12.2 Global Tetrabenazine Market Forecast by Regions (2019-2024)
12.3 North America Tetrabenazine Revenue Market Forecast (2019-2024)
12.4 Europe Tetrabenazine Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Tetrabenazine Revenue Market Forecast (2019-2024)
12.6 South America Tetrabenazine Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Tetrabenazine Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Tetrabenazine Picture
Table Product Specifications of Tetrabenazine
Table Global Tetrabenazine and Revenue (Million USD) Market Split by Product Type
Figure Global Tetrabenazine Revenue Market Share by Types in 2018
Figure 12.5 mg Tablets Picture
Figure 25 mg Tablets Picture
Table Global Tetrabenazine Revenue (Million USD) by Application (2014-2024)
Figure Tetrabenazine Revenue Market Share by Applications in 2018
Figure Huntington's disease Picture
Figure Tourette syndrome and other tic disorders Picture
Figure Tardive dyskinesia Picture
Table Global Market Tetrabenazine Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Tetrabenazine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Tetrabenazine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Tetrabenazine Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Tetrabenazine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Tetrabenazine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Tetrabenazine Revenue (Million USD) and Growth Rate (2014-2024)
Table Lundbeck Basic Information, Manufacturing Base and Competitors
Table Lundbeck Tetrabenazine Type and Applications
Table Lundbeck Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Labs Limited Basic Information, Manufacturing Base and Competitors
Table Hetero Labs Limited Tetrabenazine Type and Applications
Table Hetero Labs Limited Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Tetrabenazine Type and Applications
Table Sun Pharmaceutical Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
Table Bionpharma Basic Information, Manufacturing Base and Competitors
Table Bionpharma Tetrabenazine Type and Applications
Table Bionpharma Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Tetrabenazine Type and Applications
Table Lupin Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Tetrabenazine Type and Applications
Table Dr. Reddy's Laboratories Tetrabenazine Revenue, Gross Margin and Market Share (2017-2018)
Table Global Tetrabenazine Revenue (Million USD) by Players (2014-2019)
Table Global Tetrabenazine Revenue Share by Players (2014-2019)
Figure Global Tetrabenazine Revenue Share by Players in 2017
Figure Global Tetrabenazine Revenue Share by Players in 2018
Figure Global Top 5 Players Tetrabenazine Revenue Market Share in 2018
Figure Global Top 10 Players Tetrabenazine Revenue Market Share in 2018
Figure Global Tetrabenazine Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Tetrabenazine Revenue (Million USD) by Regions (2014-2019)
Table Global Tetrabenazine Revenue Market Share by Regions (2014-2019)
Figure Global Tetrabenazine Revenue Market Share by Regions (2014-2019)
Figure Global Tetrabenazine Revenue Market Share by Regions in 2018
Figure North America Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Europe Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure South America Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Tetrabenazine Revenue and Growth Rate (2014-2019)
Table North America Tetrabenazine Revenue by Countries (2014-2019)
Table North America Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure North America Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure North America Tetrabenazine Revenue Market Share by Countries in 2018
Figure USA Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Canada Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Mexico Tetrabenazine Revenue and Growth Rate (2014-2019)
Table Europe Tetrabenazine Revenue (Million USD) by Countries (2014-2019)
Figure Europe Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure Europe Tetrabenazine Revenue Market Share by Countries in 2018
Figure Germany Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure UK Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure France Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Russia Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Italy Tetrabenazine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Tetrabenazine Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Tetrabenazine Revenue Market Share by Countries in 2018
Figure China Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Japan Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Korea Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure India Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Tetrabenazine Revenue and Growth Rate (2014-2019)
Table South America Tetrabenazine Revenue by Countries (2014-2019)
Table South America Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure South America Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure South America Tetrabenazine Revenue Market Share by Countries in 2018
Figure Brazil Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Argentina Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Colombia Tetrabenazine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Tetrabenazine Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tetrabenazine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Tetrabenazine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure UAE Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Egypt Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure Nigeria Tetrabenazine Revenue and Growth Rate (2014-2019)
Figure South Africa Tetrabenazine Revenue and Growth Rate (2014-2019)
Table Global Tetrabenazine Revenue (Million USD) by Type (2014-2019)
Table Global Tetrabenazine Revenue Share by Type (2014-2019)
Figure Global Tetrabenazine Revenue Share by Type (2014-2019)
Figure Global Tetrabenazine Revenue Share by Type in 2019
Table Global Tetrabenazine Revenue Forecast by Type (2019-2024)
Figure Global Tetrabenazine Market Share Forecast by Type (2019-2024)
Figure Global 12.5 mg Tablets Revenue Growth Rate (2014-2019)
Figure Global 25 mg Tablets Revenue Growth Rate (2014-2019)
Table Global Tetrabenazine Revenue by Application (2014-2019)
Table Global Tetrabenazine Revenue Share by Application (2014-2019)
Figure Global Tetrabenazine Revenue Share by Application (2014-2019)
Figure Global Tetrabenazine Revenue Share by Application in 2019
Table Global Tetrabenazine Revenue Forecast by Application (2019-2024)
Figure Global Tetrabenazine Market Share Forecast by Application (2019-2024)
Figure Global Huntington's disease Revenue Growth Rate (2014-2019)
Figure Global Tourette syndrome and other tic disorders Revenue Growth Rate (2014-2019)
Figure Global Tardive dyskinesia Revenue Growth Rate (2014-2019)
Figure Global Tetrabenazine Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Tetrabenazine Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Tetrabenazine Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Tetrabenazine Revenue Market Forecast (2019-2024)
Figure Europe Tetrabenazine Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Tetrabenazine Revenue Market Forecast (2019-2024)
Figure South America Tetrabenazine Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Tetrabenazine Revenue Market Forecast (2019-2024)
世界のエトラビリン市場予測（～2024年） Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…- 世界のアルモダフィニル市場予測（～2024年） Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil. Scope of the Report: The global Armodafinil market is valued at xx million USD in 2018 and is expected to reach xx million USD by th…
- 世界の口腔内崩壊錠市場予測（～2024年） An Orodispersible Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form…
- 世界のホワイトボックス錠市場予測（～2024年） White-box tabet is a new kind of tablet, without a well-known brand name. Regarding to the ststistics from original equipment manufacturer (OEM), white box tablet manufacturers continues to dominate global tablet market, especially Chinese white box devices producers. Scope of the Report: The worldw…
- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…